Celebrating its twenty-fifth anniversary this year, the Affiliate has planned events both social and professional to highlight its member contributions, including the new Operations Management Good Practice Guide, which boasts two Italian leaders: Giuseppe Ravizzini of Recordati and Marzio Mercuri of Polpharma. The Board is planning and organizing events based in Milan, Bologna, and Rome on a variety of subjects, such as Industry 4.0 and operational excellence, data integrity, serialization and track & trace, elemental impurities, new information and communications technology trends in good practices, powder-handling safety, and nutraceuticals.
Promoting the ISPE Italy brand and its message of knowledge-sharing and collaboration ranks high on Minero’s list of objectives for 2017. In addition to “making room” for members outside of traditional pharma, “like Brazil and San Diego are doing on nutraceuticals,” Minero and the Board want the affiliate to be more present at other association conferences and trade shows, for example. “It felt great to deliver a speech as an ISPE representative last spring at the Paperless Lab Academy in Barcelona,” she recalled. Her presentation, “Paperless and Data Integrity: Different Paths, Same Goal,” was also an opportunity to promote ISPE, GAMP, and the benefits of membership. “We need to be more visible, to create and participate in working groups, write articles and make everybody aware of ISPE’s great body of knowledge,” said Minero. “If knowledge sharing and networking are our true values, we need to ‘live’ them,” she added.
On a personal and professional level, Minero tries to stay true to her values. She believes in the power and passion of groups, and the responsibility of sharing knowledge. “Our Board members are passionate about ISPE Italy—they always have been,” she said. “They want things to work well, and for us to create even stronger ties with members, both current and future.
“The view that the pharma industry needs to redeem its reputation is a matter of fact. The sciences sector has improved the quality of many lives, and it continues to achieve new and important goals, even if sometimes it is forgotten by media and social networks. We have to remind colleagues within the pharma industry, but especially to everybody outside it, that people are the end of our supply chain. Our children, our mothers, and our friends—they are affected by the work we do every day; their better health is what drives our professional community. This is our value, and the message we need to get across.”